Akums Drugs and Pharmaceuticals Ltd

Akums reported Q4 FY26 operating revenue of ₹1,158 crore, up 9.7% YoY, with Adj EBITDA surging 61.6% to ₹152 crore. CDMO business was the key driver with revenue of ₹952 crore and EBITDA margin expans